Apr 29, 2016 12:39 pm UTC| Business
MAROUSSI, Greece, April 29, 2016 -- Pyxis Tankers Inc. (NASDAQ Cap Mkts: PXS), an emerging growth pure play product tanker company, today announced the following: Date of Earnings Release. We will issue our unaudited...
CORRECTION: REXEL :Q1 2016 RESULTS (unaudited)
Apr 29, 2016 11:12 am UTC| Business
Paris, France, April 29, 2016 -- This is a correction of the announcement from 07:30 29.04.2016 CEST. Reason for the correction: missing tables in the appendix Q1 2016 RESULTS (unaudited) SEQUENTIAL IMPROVEMENT IN...
Morrison's ruling on Kidman & Co sale redefines the national interest test
Apr 29, 2016 09:46 am UTC| Insights & Views Business
In making a preliminary decision on the sale of S. Kidman Co to a Chinese consortium, the Treasurer Scott Morrison has shed some light on what the government defines as being in the national interest. He describes the...
Kidman sale to Chinese given preliminary 'no'
Apr 29, 2016 09:43 am UTC| Business
Treasurer Scott Morrison has announced that his preliminary view is that the purchase of the Kidman pastoral empire by a Chinese-dominated buyer is contrary to the national interest. The consortium, Dakang Australia,...
Annual Report 2015 Active Biotech AB (publ)
Apr 29, 2016 08:07 am UTC| Business
Active Biotech's Annual Report 2015 is now available for download at www.activebiotech.com. The Annual Report will only be digitally distributed. The English version will be available within short. LUND, Sweden,...
CGG: Enters into a Binding Agreement for the Sale of its Multi-Physics Business
Apr 29, 2016 06:37 am UTC| Business
PARIS, April 29, 2016 -- CGG announced today that it has entered into a binding agreement with NEOS for the sale of the Multi-Physics Business Line encompassing gravity, magnetic, electromagnetic and radiometric surveys...
DBV Technologies Reports March 31, 2016 Cash Position
Apr 29, 2016 05:46 am UTC| Business
MONTROUGE, France, April 29, 2016 -- DBV Technologies, (Euronext: DBV - ISIN: FR0010417345 - Nasdaq Stock Market: DBVT), a clinical-stage specialty biopharmaceutical company, today announced its cash and cash equivalents...